Trivant Custom Portfolio Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,639
Closed -$1.76M 163
2025
Q1
$1.76M Sell
19,639
-9,734
-33% -$909K 1.01% 29
2024
Q4
$2.92M Sell
29,373
-1,528
-5% -$158K 1.71% 23
2024
Q3
$3.51M Sell
30,901
-2,056
-6% -$244K 2.02% 19
2024
Q2
$4.08M Sell
32,957
-249
-0.7% -$32.1K 2.51% 10
2024
Q1
$4.38M Sell
33,206
-942
-3% -$116K 2.79% 8
2023
Q4
$3.72M Sell
34,148
-91
-0.3% -$9.45K 2.48% 10
2023
Q3
$3.52M Buy
34,239
+343
+1% +$37K 2.59% 9
2023
Q2
$3.91M Buy
33,896
+281
+0.8% +$31.9K 2.76% 7
2023
Q1
$3.58M Buy
+33,615
New +$3.63M 2.56% 9

Other funds holding MRK

Trivant Custom Portfolio Group's MRK Position: Q2 2025 in Review

Trivant Custom Portfolio Group sold out of Merck (MRK) in Q2 2025, closing a stake of 19,639 shares — an estimated $1.76M sold.

Trivant Custom Portfolio Group first reported a position in MRK in Q1 2023 and held it in 9 quarters. The position peaked at $4.38M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Trivant Custom Portfolio Group reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Trivant Custom Portfolio Group sold 19,639 Merck shares in Q2 2025, an estimated $1.76M.
  • Trivant Custom Portfolio Group first reported a position in Merck in Q1 2023 and held it in 9 quarters.
  • Trivant Custom Portfolio Group's Merck position peaked at $4.38M in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Trivant Custom Portfolio Group's 13F filing for Q2 2025, filed 12 Aug 2025.